ABPI joins the Sustainable Medicines Partnership

07 September 2022 Posted in News by Press Office

YewMaker, the executive lead of the Sustainable Medicines Partnership (SMP), has announced that the Association of the British Pharmaceutical Industry (ABPI) has joined the partnership as a founding collaborator. The SMP is a not-for-profit private-public collaboration executing projects to make the use of medicines more sustainable.

The Sustainable Medicines Partnership is an important opportunity to bring together programmes and collaborators across the healthcare sector and to continue the drive to develop medicines in the most environmentally sustainable way possible. Steve Hoare, ABPI Director of Quality, Regulatory Science and Safety Policy

Steve Hoare, the ABPI's Quality, Regulatory Science and Safety Policy Director said: 

The ABPI is delighted to join the Sustainable Medicines Partnership. Our members are already taking significant action to reduce their environmental footprint, including cutting carbon emissions, reducing waste, and saving water.

The SMP is an important opportunity to bring together programmes and collaborators across the healthcare sector and to continue the drive to develop medicines in the most environmentally sustainable way possible.

TAGS
  • Sustainability

Last modified: 20 September 2023

Last reviewed: 20 September 2023

Related news

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

Media enquiries

+44 (0) 20 7747 7147​​